Baker Tilly International commissioned Acuris Studios to gauged the opinions of 150 dealmakers on global M&A opportunities, trends and challenges.
M&A advisors with expertise in the technology sector
News
Latest Sectoral Reports |
There is not content matching the selected criteria
Last Entries
UALA: PERSONAL FINANCE IN ARGENTINA
We analyse from a Corporate Finance perspective the third share sale of the Argentinean fintech Ualá, for $150M.
AMPER BUYS TWO TECHNOLOGY COMPANIES
We analyse from a corporate finance perspective how Amper has acquired the 100% of two Spanish technology companies belonging to the Setelsa group.
AMADIX: BIOMEDICINE AGAINST CANCER
We analyse from a corporate finance perspective the sale of shares in the biotech company Amadix, valued at around €3.2m.
BROOMX: IMMERSIVE VIRTUAL REALITY
Broomx Technologies sells part of its shares to new investors such as Wayra, Telefónica's investment vehicle, for €2M. We analyse it from Corporate Finance.
THREE HILLS BUYS PART OF GOAL SYSTEMS
We analyse from a corporate finance perspective the minority investment acquired by private equity firm Three Hills Capital Partners in Goal Systems for €45m.
BRAZILIAN LINX ACQUIRES SETA DIGITAL
Brazilian company Linx buys Seta Digital to continue its growth. We analyse it from a Corporate Finance perspective.
TEVEC: ARTIFICIAL INTELLIGENCE IN BRAZIL
We analyse from the corporate finance perspective the 1.2M$ sale of shares in the Brazilian company Tevec, specialised in Artificial Intelligence.
FOR INFRASPEAK: MANAGEMENT SOFTWARE IN PORTUGAL
Portugal's Infraspeak has sold part of its shares to new investors such as Indico Capital Partners for €3m. We analyse it from a corporate finance perspective.
SYNERGIE BUYS SPANISH COMPANY TIGLOO
We look at Synergie's acquisition of Spanish technology solutions company Tigloo from a corporate finance perspective.
IDWALL: CYBERSECURITY IN BRAZIL
Idwall, a Brazilian identity validation and fraud prevention solutions company, sells part of its shares for 10M$. We look at it from a corporate finance perspective.
BIGFINITY: IA IN PHARMACEUTICAL MANUFACTURING
We analyse from Corporate Finance, the second share sale of Bigfinity, specialist in SaaS platforms for pharmaceutical and biotech industries, for 15M$.